Key result
Methodological limitations in current global statistics may underrate the true CVD burden in sub-Saharan Africa.
Why the study?
The 2010 global burden of disease estimates have been cited to suggest sub-Saharan Africa is exempt from the cardiovascular disease epidemic, despite indications of a rapid increase in CVD prevalence by 2030.
This review emphasizes the need for accurate, cost-effective surveillance of cardiovascular disease in sub-Saharan Africa, challenging the premise that the region is exempt from the global CVD epidemic.
Challenges assumptions of low regional CVD burden; leaves open need for improved surveillance before revising priorities.
Background. Although 80% of the burden of cardiovascular disease (CVD) is in developing countries, the 2010 global burden of disease (GBD) estimates have been cited to support a premise that sub-Saharan Africa (SSA) is exempt from the CVD epidemic sweeping across developing countries. The widely publicized perspective influences research priorities and resource allocation at a time when secular trends indicate a rapid increase in prevalence of CVD in SSA by 2030. Purpose. To explore methodological challenges in estimating trends and burden of CVD in SSA via appraisal of the current CVD statistics and literature. Methods. This review was guided by the Critical review methodology described by Grant and Booth. The review traces the origins and evolution of GBD metrics and then explores the methodological limitations inherent in the current GBD statistics. Articles were included based on their conceptual contribution to the existing body of knowledge on the burden of CVD in SSA. Results/Conclusion. Cognizant of the methodological challenges discussed, we caution against extrapolation of the global burden of CVD statistics in a way that underrates the actual but uncertain impact of CVD in SSA. We conclude by making a case for optimal but cost-effective surveillance and prevention of CVD in SSA.
No takes yet. Share an insight, caveat, or question.
Kariuki et al. (2015) conducted a review in Cardiovascular disease. Global burden of disease (GBD) statistics was evaluated. Current global burden of disease statistics have methodological limitations that may underrate the actual but uncertain impact of cardiovascular disease in sub-Saharan Africa.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: